financetom
BKYI
financetom
/
Industrials
/
BKYI
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
BIO-key International, Inc.BKYI
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally.

The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform.

Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative.

In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions that develops finger-based biometric technology.

Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names.

The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002.

BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.

Latest News >
Neurocrine Biosciences Says Late-Stage Movement Disorder Study Shows Ingrezza's Therapeutic Efficacy at Lowest Available Dose
Neurocrine Biosciences Says Late-Stage Movement Disorder Study Shows Ingrezza's Therapeutic Efficacy at Lowest Available Dose
Oct 17, 2025
09:29 AM EDT, 10/17/2025 (MT Newswires) -- Neurocrine Biosciences ( NBIX ) said Friday that a new post-hoc analysis of a late-stage study showed clinically meaningful improvements in tardive dyskinesia symptoms in patients treated with Ingrezza at the lowest available dose of 40 mg. The company said 90% of participants who received continuous treatment for 48 weeks improved by at...
Embraer, Mahindra expand partnership to develop C-390 Millennium in India
Embraer, Mahindra expand partnership to develop C-390 Millennium in India
Oct 17, 2025
SAO PAULO, Oct 17 (Reuters) - The defense and security division of Brazilian planemaker Embraer ( ERJ ) said on Friday it had signed a strategic cooperation agreement with India's Mahindra Group, including joint initiatives for the development and production of the C-390 Millennium aircraft in India. The agreement supports the promotion of the C-390 Millennium aircraft for the Indian...
AbbVie Closes Bretisilocin Acquisition
AbbVie Closes Bretisilocin Acquisition
Oct 17, 2025
09:28 AM EDT, 10/17/2025 (MT Newswires) -- AbbVie ( ABBV ) said Friday it has closed the acquisition of Gilgamesh Pharmaceuticals' lead investigational candidate bretisilocin. Bretisilocin is a psychedelic compound in phase 2 clinical development for the treatment of patients with moderate to severe major depressive disorder, AbbVie ( ABBV ) said. ...
OBOOK Shares Fall Pre-Bell After Nasdaq Listing
OBOOK Shares Fall Pre-Bell After Nasdaq Listing
Oct 17, 2025
09:27 AM EDT, 10/17/2025 (MT Newswires) -- OBOOK ( OWLS ) shares were down 38% in Friday premarket activity, continuing their losses after the company's Nasdaq listing on Thursday. The company's shares closed at $55.55 on Thursday, down 18% from their $68 per share opening price. The company said that at the closing price on Thursday its market capitalization was...
Copyright 2023-2026 - www.financetom.com All Rights Reserved